| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $212.8M | +10.7% |
| Cost of Revenue | $39.0M | +35.3% |
| R&D Expense | $127.1M | +30.9% |
| SG&A Expense | $67.7M | +23.9% |
| Operating Income | -$144.2M | -52.1% |
| Pre-tax Income | -$136.2M | -43.2% |
| Income Tax | $1.7M | +965.6% |
| Net Income | -$137.9M | -44.7% |
| EPS (Basic) | -$0.36 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.2M | -89.4% |
| Accounts Receivable | $29.8M | +0.3% |
| Current Assets | $625.3M | -17.9% |
| Total Assets | $699.6M | -16.7% |
| Current Liabilities | $34.7M | +3.5% |
| Total Liabilities | $88.5M | -6.9% |
| Stockholders' Equity | $611.1M | -18.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.5M | -18.0% |
| Capital Expenditures | $3.2M | -64.3% |
| Investing Cash Flow | -$342.4M | -129.0% |
| Financing Cash Flow | -$64.3M | -110.1% |
| Free Cash Flow | -$63.7M | -5.9% |
| +44.6% |
| EPS (Diluted) | -$0.36 | +44.6% |